Effects of Autogenic Inhibition and Reciprocal Inhibition in Amateur Football Players With Shin Splints.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 12, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different treatment methods—Autogenic Inhibition and Reciprocal Inhibition—to help amateur football players aged 18-30 who are experiencing shin splints, which is a common injury that causes pain in the lower legs. The trial involves players from the SA Gardens Football Club in Lahore, and it aims to find out which method is more effective in reducing pain, improving flexibility, and enhancing overall sports performance over a four-week period with three treatment sessions each week.

To be eligible to participate, players must be between 18 and 30 years old, have been actively involved in sports for at least a year, and experience moderate to severe pain from shin splints. However, those with certain medical histories, such as recent leg injuries or surgeries, will not be able to join. Participants can expect to receive one of the two treatments in a single-blind setup, meaning they won’t know which method they are getting, and the results will help inform better treatment options for athletes dealing with shin splints.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Both genders.
• • 2. Age 18-30 years.
• • 3. Those who are actively taking part in sports from last 1 year.
• • 4. Subjects who have NPRS scores from moderate pain (NPRS 4-6) to severe pain (NPRS 7- 10).
• • 5. Subjects diagnosed with category 2 Shin splints through Shin splint scoring system (Male 2- 14, Female 6-16) and category 3 (Male 14-29, Female 17-29).
• Exclusion Criteria:
• • 1. History of Central or peripheral vascular disease.
• • 2. History of lower limb fracture / Trauma (Any side) in last 6 months.
• • 3. History of lower limb Surgery (Any side) in last 6 months.
• • 4. History of any malignancy.
• • 5. Leg length discrepancy.
• • 6. Biomechanical imbalances.